The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer (Q40281819)
Jump to navigation
Jump to search
scientific article published on October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer |
scientific article published on October 2006 |
Statements
1 reference
The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer (English)
1 reference
1 reference
Mara Rendi
1 reference
Nanjoo Suh
1 reference
Darlene B Royce
1 reference
Renee Risingsong
1 reference
Charlotte R Williams
1 reference
William Lamph
1 reference
Fernand Labrie
1 reference
Stan Krajewski
1 reference
Xiaochun Xu
1 reference
Heetae Kim
1 reference
Powel Brown
1 reference
Michael B Sporn
1 reference
1 October 2006
1 reference
1 reference
12
1 reference
19
1 reference
5902-5909
1 reference
Identifiers
1 reference
1 reference